Unknown

Dataset Information

0

Hypertensive disorders in pregnancy and child development at 36 months in the All Our Families prospective cohort study.


ABSTRACT: Hypertensive disorders in pregnancy (HDP) are associated with increased risk of offspring neurodevelopmental disorders, suggesting long-term adverse impacts on fetal brain development. However, the relationship between HDP and deficits in general child development is unclear. Our objective was to assess the association between HDP and motor and cognitive developmental delay in children at 36 months of age. We analyzed data from the All Our Families community-based cohort study (n = 1554). Diagnosis of HDP-gestational or chronic hypertension, preeclampsia, or eclampsia-was measured through medical records. Child development was measured by maternal-report on five domains of the Ages and Stages Questionnaire (ASQ-3). Standardized cut-off scores were used to operationalize binary variables for any delay, motor delay, and cognitive delay. We calculated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) using logistic regression, sequentially controlling for potential confounders followed by factors suspected to lie on the causal pathway. Overall, 8.0% of women had HDP and hypertension-exposed children had higher prevalence of delay than unexposed children. Hypertension-exposed children had elevated risk for developmental delay, but CIs crossed the null. The aRRs quantifying the fully adjusted effect of HDP on child development were 1.19 (95% CI 0.92, 1.53) for any delay, 1.18 (95% CI 0.86, 1.61) for motor delay, and 1.24 (95% CI 0.83, 1.85) for cognitive delay. We did not find a statistically significant association between HDP and developmental delay. Confidence intervals suggest that children exposed to HDP in utero have either similar or slightly elevated risk of any, motor, and cognitive delay at 36 months after controlling for maternal and obstetric characteristics. The observed direction of association aligns with evidence of biological mechanisms whereby hypertensive pathology can disrupt fetal neurodevelopment; however, more evidence is needed. Findings may have implications for early developmental monitoring and intervention following prenatal hypertension exposure.

SUBMITTER: Scime NV 

PROVIDER: S-EPMC8635344 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8048729 | biostudies-literature
| S-EPMC6955541 | biostudies-literature
| S-EPMC4312021 | biostudies-literature
| S-EPMC6601621 | biostudies-literature
| S-EPMC7720658 | biostudies-literature
| S-EPMC6382119 | biostudies-literature
| S-EPMC9183033 | biostudies-literature
| S-EPMC7978343 | biostudies-literature
| S-EPMC9045052 | biostudies-literature
| S-EPMC4061469 | biostudies-literature